EcoR1 Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-17,060
Closed -$1.09M 33
2017
Q3
$1.09M Hold
17,060
0.14% 36
2017
Q2
$951K Hold
17,060
0.17% 32
2017
Q1
$928K Buy
17,060
+8,500
+99% +$466K 0.23% 27
2016
Q4
$500K Buy
+8,560
New +$468K 0.16% 30

Other funds holding BMY

EcoR1 Capital's BMY Position: Q4 2017 in Review

EcoR1 Capital sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 17,060 shares — an estimated $1.09M sold.

EcoR1 Capital first reported a position in BMY in Q4 2016 and held it in 4 quarters. The position peaked at $1.09M in Q3 2017. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • EcoR1 Capital reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
  • EcoR1 Capital sold 17,060 Bristol-Myers Squibb shares in Q4 2017, an estimated $1.09M.
  • EcoR1 Capital first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 4 quarters.
  • EcoR1 Capital's Bristol-Myers Squibb position peaked at $1.09M in Q3 2017.
  • 1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on EcoR1 Capital's 13F filing for Q4 2017, filed 14 Feb 2018.